CD34 and chronic myelogenous leukemia, BCR-ABL1 positive: XBP1-SE supported survival and self-renewal capacity in primary CML CD34+ cells, but eradicated LSCs in CML mice and impaired the leukemogenesis of LSCs in CML mice after the knockdown of XBP1 [148].